<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Ipsen McDonough | Activity</title>
	<link>https://www.catswannabecats.com/members/cementbadge25/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/cementbadge25/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Ipsen McDonough.</description>
	<lastBuildDate>Sat, 27 Jun 2026 18:58:01 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ff09afc7cbc1f198899390af88966da5</guid>
				<title>Ipsen McDonough posted an update: COVID-19 sepsis is characterized by acute respiratory [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24485/</link>
				<pubDate>Sun, 08 Jun 2025 12:47:28 -0400</pubDate>

									<content:encoded><![CDATA[<p>COVID-19 sepsis is characterized by acute respiratory distress syndrome (ARDS) as a consequence of pulmonary tropism of the virus and endothelial heterogeneity of the host. ARDS is a phenotype among patients with multiorgan dysfunction syndrome (MODS) due to disseminated vascular microthrombotic disease (VMTD). In response to the viral septicemia,&hellip;<span class="activity-read-more" id="activity-read-more-24485"><a href="https://www.catswannabecats.com/activity/p/24485/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0183f87b8a151f8dc72b5fbde47c38f4</guid>
				<title>Ipsen McDonough posted an update: Available reports suggest that RLX could induce ECM [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21311/</link>
				<pubDate>Fri, 06 Jun 2025 13:24:56 -0400</pubDate>

									<content:encoded><![CDATA[<p>Available reports suggest that RLX could induce ECM remodeling and suppress the profibrogenic transforming growth factor-β signaling and thereby regress hepatic fibrosis. Though RLX has natural antifibrotic activity, its antifibrotic molecular mechanisms especially in hepatic fibrosis condition are not reported. This review exclusively focuses&hellip;<span class="activity-read-more" id="activity-read-more-21311"><a href="https://www.catswannabecats.com/activity/p/21311/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4e1252f5d5451a232f692250897fbc69</guid>
				<title>Ipsen McDonough posted an update: Available reports suggest that RLX could induce ECM [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21218/</link>
				<pubDate>Fri, 06 Jun 2025 13:08:48 -0400</pubDate>

									<content:encoded><![CDATA[<p>Available reports suggest that RLX could induce ECM remodeling and suppress the profibrogenic transforming growth factor-β signaling and thereby regress hepatic fibrosis. Though RLX has natural antifibrotic activity, its antifibrotic molecular mechanisms especially in hepatic fibrosis condition are not reported. This review exclusively focuses&hellip;<span class="activity-read-more" id="activity-read-more-21218"><a href="https://www.catswannabecats.com/activity/p/21218/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">32a72ff646129a7c21c64740b6ced2ac</guid>
				<title>Ipsen McDonough posted an update: Early discontinuation of adjuvant endocrine therapy (ET) is [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19082/</link>
				<pubDate>Wed, 04 Jun 2025 12:24:20 -0400</pubDate>

									<content:encoded><![CDATA[<p>Early discontinuation of adjuvant endocrine therapy (ET) is problematic among breast cancer survivors, with previous studies suggesting that up to 50% of women do not adhere to the recommended full 5 years of ET treatment.</p>
<p> To identify the association between early discontinuation of ET in the Trial Assigning Individualized Options for&hellip;<span class="activity-read-more" id="activity-read-more-19082"><a href="https://www.catswannabecats.com/activity/p/19082/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">50859d90e6bb611e695aff605cf47a38</guid>
				<title>Ipsen McDonough posted an update: Electrochemical decarboxylation of aryloxyacetic acids [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4278/</link>
				<pubDate>Sat, 31 May 2025 12:28:07 -0400</pubDate>

									<content:encoded><![CDATA[<p>Electrochemical decarboxylation of aryloxyacetic acids followed by fluorination provides easy access to fluoromethyl aryl ethers. This electrochemical fluorodecarboxylation offers a sustainable approach with electric current as traceless oxidant. Using Et3N·5HF as fluoride source and as supporting electrolyte, this simple electrosynthesis affords&hellip;<span class="activity-read-more" id="activity-read-more-4278"><a href="https://www.catswannabecats.com/activity/p/4278/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">50c022b718af53e0c488e6ba20f78148</guid>
				<title>Ipsen McDonough became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4110/</link>
				<pubDate>Sat, 31 May 2025 12:09:56 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>